The importance of HLA for the development of cell therapies

Thanks to a greater understanding of human leukocyte antigen (HLA) function, researchers can now work toward developing new cancer immunotherapies.

The HLA (human leukocyte antigen) system of cell surface proteins contributes to the regulation of the immune system. Yet certain antigens can make a significant difference. Patients with some types of HLA are at higher risk for autoimmune diseases, infectious diseases, or cancer. Thanks to an improved understanding of HLA function, researchers can now develop new cancer immunotherapies.

Our Product Manager for cells and media and HLA expert Lisa Hamelmann will talk you through the following topics:

  • HLA restriction: finding and binding
  • HLA and diseases: activating autoimmune responses
  • HLA and cancer: how cancer cells escape recognition
  • New therapeutic options: harnessing HLA for cancer immunotherapy
  • HLA-typed cells: an important control system to test new immunotherapies

Download the white paper

Learn more about the significance HLA has for developing cell therapies.

Download here

Choose your Region

Please choose your region for an optimized website experience. So we can provide you with the most useful information for your country.

  1. North America
    1. Canada
    2. United States
  2. Europe
    1. Austria
    2. Belgium
    3. Bulgaria
    4. Croatia
    5. Czech Republic
    6. Denmark
    7. Finland
    8. France
    9. Germany
    10. Greece
    11. Hungary
    12. Ireland
    13. Italy
    14. Luxembourg
    15. Monaco
    16. Netherlands
    17. Norway
    18. Poland
    19. Portugal
    20. Romania
    21. Slovakia
    22. Slovenia
    23. Spain
    24. Sweden
    25. Switzerland
    26. United Kingdom
  3. Asia
    1. India
    2. Israel
    3. Japan
    4. Malaysia
    5. Singapore
    6. South Korea
    7. Taiwan
    8. Thailand
Scroll to top